Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study.
Madeleine J KarpinskiJohannes HüsingKevin ClaassenLennart MöllerHiltraud KajüterFlorian OesterlingViktor GrünwaldLale UmutluJens KleesiekTugce TelliAnja Merkel-JensAnika HüsingClaudia KeschKen HerrmannMatthias EiberSebastian HoberückPhilipp T MeyerFelix KindKambiz RahbarMichael SchäfersAndreas StangBoris A HadaschikWolfgang P FendlerPublished in: The Lancet. Oncology (2024)
Cancer Registry North-Rhine Westphalia.